Back
Viridian Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
10
VRDN
Viridian Therapeutics
Last Price:
17.86
Seasonality Move:
4.07%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRDN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Viridian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.13 | Sell |
| 20-day SMA: | 20.04 | Sell |
| 50-day SMA: | 22.07 | Sell |
| 200-day SMA: | 17.26 | Buy |
| 8-day EMA: | 19.02 | Sell |
| 20-day EMA: | 20.11 | Sell |
| 50-day EMA: | 20.77 | Sell |
| 200-day EMA: | 18.83 | Sell |
Viridian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 28.9 | Sell |
| Chaikin Money Flow: | 962684 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.9 - 22.56) | Sell |
| Bollinger Bands (100): | (16.25 - 23.31) | Sell |
Viridian Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics Stock
Is Viridian Therapeutics Stock a Buy?
- Viridian Therapeutics share price is 17.85 while VRDN 8-day simple moving average is 19.13, which is a Sell signal.
- The stock price of VRDN is 17.85 while Viridian Therapeutics 20-day SMA is 20.04, which makes it a Sell.
- Viridian Therapeutics 50-day simple moving average is 22.07 while VRDN share price is 17.85, making it a Sell technically.
- VRDN stock price is 17.85 and Viridian Therapeutics 200-day simple moving average is 17.26, creating a Buy signal.
VRDN Technical Analysis vs Fundamental Analysis
Sell
10
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a Sell
The current Viridian Therapeutics [VRDN] share price is $17.85. The Score for VRDN is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Viridian Therapeutics Stock Info
Market Cap:
1.41B
Price in USD:
17.85
Share Volume:
1.55M
Viridian Therapeutics 52-Week Range
52-Week High:
27.20
52-Week Low:
11.40
Sell
10
Viridian Therapeutics (VRDN)
is a Sell
Viridian Therapeutics Share Price Forecast
-
What is the Viridian Therapeutics stock price today?
The Viridian Therapeutics stock price is 17.85 USD today. -
Will VRDN stock go up or go down?
Viridian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viridian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics is overvalued.
Is Viridian Therapeutics Stock a Buy?
- Viridian Therapeutics share price is 17.85 while VRDN 8-day exponential moving average is 19.02, which is a Sell signal.
- The stock price of VRDN is 17.85 while Viridian Therapeutics 20-day EMA is 20.11, which makes it a Sell.
- Viridian Therapeutics 50-day exponential moving average is 20.77 while VRDN share price is 17.85, making it a Sell technically.
- VRDN stock price is 17.85 and Viridian Therapeutics 200-day simple moving average is 18.83, creating a Sell signal.
Fundamental Analysis of Viridian Therapeutics
Is Viridian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Viridian Therapeutics
Should I short Viridian Therapeutics stock?
- VRDN Moving Average Covergence Divergence (MACD) indicator is -0.98, suggesting Viridian Therapeutics is a Sell
- Viridian Therapeutics Relative Strength Index (RSI) is 28.9, which suggest Viridian Therapeutics is oversold
- The Bollinger Bands (25) for Viridian Therapeutics is (18.9 - 22.56), which suggest Viridian Therapeutics is a Sell
- The Bollinger Bands (100) for Viridian Therapeutics is (16.25 - 23.31), which suggest Viridian Therapeutics is a Sell
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.